Clinical Trials Logo

Advanced Breast Cancer Female clinical trials

View clinical trials related to Advanced Breast Cancer Female.

Filter by:
  • None
  • Page 1

NCT ID: NCT02600923 Completed - Clinical trials for Advanced Breast Cancer Female

Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate

Start date: April 15, 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to provide access to palbociclib in Mexico and in selected Latin American countries before it becomes commercially available to patients with HR positive/HER2-negative ABC who are appropriate candidates for letrozole therapy.

NCT ID: NCT02142868 No longer available - Clinical trials for Advanced Breast Cancer (Female)

Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate

Start date: n/a
Phase:
Study type: Expanded Access

To provide access to palbociclib to post-menopausal women with HR-positive, HER2-negative advanced breast cancer who are deemed appropriate for letrozole therapy (Canada: first-line patients only).